← SynDRA
TUBASTATIN A
SynDRA canonical compound SYN0029048 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HDAC6 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC1 INHIBITOR
- HDAC6 INHIBITOR
- HDAC8 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC10
- HDAC11
- HDAC2
- HDAC3
- HDAC4
- HDAC5
- HDAC7
- HDAC9
- AR
- PIK3CD
- SIRT2
- SIRT5
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- CP2D6
- GAMT
- GNMT
- HNMT
- KSYK
- NCOR2
- NNMT
- NSD2
- PNMT
- SYK
- TP53
Cross-references
Synonyms
- TUBASTATIN-A
- TUBASTATIN A BASE
- tubastatin-a
- 2XTSOX1NF8
- CHEBI:94186
- RefChem:192427
- DTXCID401747869
- Tubastatin A BASE
- Tubastatin A (free base)
- Tubastatin A(free base)
- UNII-2XTSOX1NF8
- MFCD18071463
- Tubastatin A (trifluoroacetate)
- Tubastatin A Trifluoroacetic Acid Salt
- N9W
- MLS006011088
- GTPL9702
- orb1306944
- SCHEMBL1057119
- SCHEMBL29356061
- EX-A685
- GOVYBPLHWIEHEJ-UHFFFAOYSA-N
- GLXC-05137
- HMS3656P20
- HMS3744E15
- BDBM50380399
- HY-13271A
- AKOS027422742
- CCG-267860
- CS-5376
- SB19289
- NCGC00263606-03
- NCGC00263606-15
- NCGC00263606-19
- AS-16945
- BP-40077
- DA-46698
- SMR004702876
- SY096619
Look up TUBASTATIN A in the interactive SynDRA portal →